CYCC Bio Green Med Solution Inc.


$ 1.43 $ 0.05 (3.68 %)    

Wednesday, 12-Nov-2025 10:33:00 EST
QQQ $ 620.78 $ -3.99 (-0.64 %)
DIA $ 483.58 $ 3.04 (0.63 %)
SPY $ 683.64 $ -1.13 (-0.17 %)
TLT $ 90.18 $ 0.24 (0.26 %)
GLD $ 386.29 $ 6.14 (1.62 %)
$ 1.4
$ 1.36
$ 1.40 x 2,000
$ 1.43 x 50
$ 1.39 - $ 1.41
$ 1.33 - $ 101.30
43,881
na
na
$ 1.30
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION